CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing demand for personalised medicines
4.1.2. Rising orphan drugs developments
4.1.3. Rising biopharmaceuticals and biologics industry
4.1.4. Increase in incidences of lifestyle diseases such as diabetes and cancer
4.1.5. Growing popularity of single-use bioreactor among biopharmaceutical companies.
4.2. Market Restraints & Challenges
4.2.1. Concerns regarding extractable
4.2.2. Low capacity of single-use bioreactor
4.3. Market Opportunities
4.3.1. Emerging markets
4.3.2. Technological advancements in bioreactors
CHAPTER 5. GLOBAL BIOREACTORS MARKET – BY CELL
5.1. Bacterial cells
5.2. Yeast cells
5.3. Others
CHAPTER 6. GLOBAL BIOREACTORS MARKET – BY MOLECULE
6.1. Vaccines
6.2. Recombinant protein
6.3. Stem cell
6.4. Gene Therapy
6.5. Others
CHAPTER 7. GLOBAL BIOREACTORS MARKET – BY TECHNOLOGY
7.1. Wave-induced motion SUB
7.2. Stirred SUB
7.3. Stirred use bubble column
7.4. Others
CHAPTER 8. GLOBAL BIOREACTORS MARKET – BY MATERIAL
8.1. Glass
8.2. Stainless steel
8.3. Single use
CHAPTER 9. GLOBAL BIOREACTORS MARKET – BY APPLICATION
9.1. Lab scale production
9.2. Pilot scale production
9.3. Full-scale production
CHAPTER 10. GLOBAL BIOREACTORS MARKET – BY END USER
10.1. Research and development
10.2. Biopharma manufacturers
10.3. Contract manufacturing organisation’s
CHAPTER 11. GLOBAL BIOREACTORS MARKET - BY GEOGRAPHY
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Costa Rica
11.3. South America
11.3.1. Brazil
11.3.2. Argentina
11.3.3. Chile
11.3.4. Columbia
11.3.5. Others
11.4. Europe
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Russia
11.4.7. Netherlands
11.4.8. Switzerland
11.4.9. Poland
11.4.10. Others
11.5. APAC
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. South Korea
11.5.5. Australia & New Zealand
11.5.6. Malaysia
11.5.7. Singapore
11.5.8. Others
11.6. Middle East & Africa
11.6.1. UAE
11.6.2. Saudi Arabia
11.6.3. Iran
11.6.4. Iraq
11.6.5. Qatar
11.6.6. South Africa
11.6.7. Algeria
11.6.8. Morocco
11.6.9. Nigeria
11.6.10. Egypt
11.6.11. Others
CHAPTER 12. GLOBAL BIOREACTORS MARKET - COMPANY PROFILES
12.1. Finesse Solutions, Inc.
12.2. Applikon Biotechnology B.V.
12.3. PBS Biotech, Inc.
12.4. Danaher Corporation
12.5. Eppendorf AG
12.6. Sartorius AG
12.7. ZETA Holding GmbH
12.8. Solaris Biotechnology srl
12.9. GE Healthcare
12.10. Pierre Guerin Technologies
12.11. Thermo Fisher Scientific Inc
12.12. Merck KGaA
12.13. CRB Consulting Engineers Inc.
12.14. Technip S.A.
12.15. Jacobs Engineering Group Inc.
CHAPTER 13. GLOBAL BIOREACTORS MARKET - COMPETITIVE LANDSCAPE
13.1. Market Share Analysis
13.2. Strategies adopted by top companies
13.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 14. MARKET INSIGHTS
14.1. Industry Experts Insights
14.2. Analysts Opinions
14.3. Investment Opportunities
CHAPTER 15. APPENDIX
15.1. List of Tables
15.2. List of Figures
